Anti-CD41 [7E3 (Abciximab)]
Ab00282-10.0
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
TargetITGA2B
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD41 [7E3 (Abciximab)]
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Neutralisation/Blocking
- Applications SupplierBlock; Fc
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7E3 (Abciximab)
- Gene ID3674
- Target nameITGA2B
- Target descriptionintegrin subunit alpha 2b
- Target synonymsBDPLT16, BDPLT2, CD41, CD41B, FMAIT2, GP2B, GPIIb, GT, GT1, GTA, HPA3, PPP1R93, integrin alpha-IIb, GPalpha IIb, alphaIIb protein, integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41), platelet fibrinogen receptor, alpha subunit, platelet glycoprotein IIb of IIb/IIIa complex, platelet membrane glycoprotein IIb, platelet-specific antigen BAK, protein phosphatase 1, regulatory subunit 93
- HostHuman
- IsotypeIgG1
- Protein IDP08514
- Protein NameIntegrin alpha-IIb
- Scientific DescriptionThis is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
- Reactivity SupplierHuman
- Reactivity Supplier NoteCD41 is the integrin alpha chain 2b forming a fibrinogen receptor in heterodimeric complex with beta 3.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203



